Positron Emission Tomography as a Surrogate Marker for Evaluation of Treatment Response in Patients with Desmoid Tumors under Therapy with Imatinib

Table 1

Patients’ characteristics (𝑛=22).

Gender
Female	16
Male	6
Age
Median (years)	42.5 (range: 22–75)
Histology
Desmoid tumor	22
Tumor site at initial diagnosis
Abdomen/trunk	17
Extremities	5
Previous treatment
None	8
Surgery alone	7
Surgery plus radiotherapy	7
Systemic treatment	2